CompletedNCT00938743
Atomoxetine and driving in adults with ADHD
About this title
Read the official source — NCT00938743Medication studyAges 18–55Germany
Understand this study
Who was this study for?
This study was for people with ADHD. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
- Listed locations
- MannheimSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJanuary 2008
- Recruitment status
- Completed
- Enrollment listed in the registry
- 50
- Sponsor
- Central Institute of Mental Health, Mannheim
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Germany
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT00938743
- Official title
Show the full official title
Driving Ability in Adults With ADHD Before and After 10-weeks of Treatment With 40-80mg Atomoxetine vs. Untreated Adults With ADHD
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Mannheim
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Central Institute of Mental Health, Mannheim, a research institute.
Did this study involve medication?
Yes. The study involved medication, including Atomoxetine.
Who was this study for?
This study was for people with ADHD. Listed age limits: 18 years to 55 years. Other eligibility criteria applied.
